We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
-11.59%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.17B
AUM Growth
-$480M
Cap. Flow
-$309M
Cap. Flow %
-26.45%
Top 10 Hldgs %
28.7%
Holding
357
New
123
Increased
35
Reduced
46
Closed
150

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$66.8M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$35.8M
3
PH icon
Parker-Hannifin
PH
+$22.3M
4
JACK icon
Jack in the Box
JACK
+$19.7M
5
YHOO
Yahoo Inc
YHOO
+$16.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 9.22%
2 Technology 9.06%
3 Healthcare 7.22%
4 Industrials 5.33%
5 Communication Services 2.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPK icon
151
Graphic Packaging
GPK
$3.45B
$1.7M 0.15%
132,740
-218,667
-62% -$3.12M
KANG
152
DELISTED
iKang Healthcare Group, Inc.
KANG
$1.7M 0.15%
114,568
-269,485
-70% -$4.36M
TCON
153
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$1.66M 0.14%
+850
New +$1.99M
JOY
154
CALL
DELISTED
Joy Global Inc
JOY
$1.57M 0.13%
105,000
+7,500
+8% +$182K
OSUR icon
155
OraSure Technologies
OSUR
$277M
$1.53M 0.13%
+345,000
New +$1.8M
WIN
156
DELISTED
Windstream Holdings Inc
WIN
$1.46M 0.13%
47,561
-51,071
-52% -$1.59M
TXMD icon
157
TherapeuticsMD
TXMD
$23.8M
$1.42M 0.12%
+4,837
New +$1.72M
SABR icon
158
Sabre
SABR
$743M
$1.41M 0.12%
+51,918
New +$1.4M
MRIN
159
CALL
DELISTED
Marin Software
MRIN
$1.39M 0.12%
+10,595
New +$2.01M
CNCE
160
PUT
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1.39M 0.12%
+74,000
New +$1.26M
CFG icon
161
Citizens Financial Group
CFG
$30.8B
$1.35M 0.12%
+56,454
New +$1.44M
SHOP icon
162
PUT
Shopify
SHOP
$169B
$1.32M 0.11%
+375,000
New +$1.19M
HRI icon
163
Herc Holdings
HRI
$4.95B
$1.32M 0.11%
+26,229
New +$1.37M
FMC icon
164
CALL
FMC
FMC
$1.37B
$1.27M 0.11%
+43,238
New +$1.68M
REZ icon
165
iShares Residential and Multisector Real Estate ETF
REZ
$906M
$1.19M 0.1%
+20,000
New +$1.17M
ZGNX
166
DELISTED
Zogenix, Inc.
ZGNX
$1.17M 0.1%
+86,885
New +$1.57M
LPX icon
167
Louisiana-Pacific
LPX
$5.35B
$1.1M 0.09%
+77,383
New +$1.23M
OI icon
168
O-I Glass
OI
$1.39B
$1.08M 0.09%
+52,375
New +$1.11M
ISIL
169
DELISTED
Intersil Corp
ISIL
$1.03M 0.09%
+88,200
New +$983K
ADMA icon
170
ADMA Biologics
ADMA
$2.04B
$1.02M 0.09%
121,756
-1,100
-0.9% -$10.2K
FINL
171
CALL
DELISTED
Finish Line
FINL
$965K 0.08%
+50,000
New +$1.32M
OLN icon
172
Olin
OLN
$2.44B
$944K 0.08%
+56,174
New +$1.19M
FIZZ icon
173
National Beverage
FIZZ
$3.05B
$905K 0.08%
+58,908
New +$754K
TVTX icon
174
Travere Therapeutics
TVTX
$5.2B
$886K 0.08%
43,734
+35,616
+439% +$1.05M
SALE
175
DELISTED
RetailMeNot, Inc. Series 1
SALE
$855K 0.07%
+103,821
New +$1.21M

Similar funds

J. Goldman & Co's Q3 2015 Portfolio in Review

As of Q3 2015, J. Goldman & Co held 357 positions worth $1.17B, down 29% from $1.65B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

J. Goldman & Co withdrew a net $309M in Q3 2015, closing 150 positions and reducing 46 holdings. Its most notable exit was PepsiCo, an estimated $66.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 9.2% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.

Against the trend, J. Goldman & Co opened a new position in Finish Line worth $22.9M.

  • J. Goldman & Co's largest Q3 2015 buy was Finish Line: 1,187,165 shares worth $22.9M.
  • J. Goldman & Co added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $31.5M increase.
  • J. Goldman & Co's biggest Q3 2015 reduction was PROS Holdings, cutting an estimated $11.1M.
  • J. Goldman & Co fully exited PepsiCo in Q3 2015, selling an estimated $66.8M.
  • J. Goldman & Co's ten largest holdings make up 29% of its $1.17B portfolio in Q3 2015.
  • J. Goldman & Co opened 123 new positions and closed 150 in Q3 2015.
  • J. Goldman & Co's portfolio value fell 29% quarter-over-quarter to $1.17B.

Based on J. Goldman & Co's 13F filing for Q3 2015, filed 16 Nov 2015.